Affymetrix (Bedford, Massachusetts) (AFFX) Clinical Services Laboratory and DOCRO Join Forces to Accelerate the Commercialization of In Vitro Diagnostic Products
7/16/2007 11:16:54 AM
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that the Affymetrix Clinical Services Laboratory (ACSL) has signed a co-marketing agreement with DOCRO Inc., a leading contract research organization (CRO) that specializes in the commercialization of in vitro diagnostic (IVD) biomarker technologies. The two companies will work together to help customers gain clearance or approval of IVD products from the U.S. Food and Drug Administration (FDA) and bring those products to market faster than before.
comments powered by